IL6 and COVID-19: The increase of pro-inflammatory cytokines, especially IL-6, is a characteristic of moderate to severe COVID-19, which can cause endothelial dysfunction, increase vascular permeability, and aggravate blood–brain barrier (BBB) dysfunction (44).